Tuesday, July 14, 2020 7:04:32 PM
Under the radar Gem Phase 3 Covid-19 Play most upside of any stock today.
Revive Therapeutics: Analyst sees 'substantial upside potential' as key assets move towards clinic
5000%-10,000% upside on approval in 2020 for Bucillamine.
Near term Catalyst
1.FDA signs off on Phase 3 Trail for Bucillamine Covid-19 that should put the market valuation between 10-20x the current price. Phase 3 drugs are valued between 300 million and 1.1 Billion. Covid-19 FDA Phase 3 arguably is worth more. This would be the only drug if approved thats not a vaccine or anti viral and has the lowest side effects compared to anything else on the market. This can be a real game changer. Also the patient population Revive Therapeutics is mild to moderate which is the largest covid-19 Patient Population. Approval we should see high double digit dollars.
2. Canadian Trial for Covid-19 Bucillamine.
3. Asian Trials for Covid-19 Bucillamine.
Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19
https://www.globenewswire.com/news-release/2020/06/30/2055779/0/en/Revive-Therapeutics-Announces-Submission-of-Investigational-New-Drug-Application-IND-with-U-S-FDA-for-Phase-3-Confirmatory-Study-for-Bucillamine-in-COVID-19.html
NVAX Covid Phase 2 Vaccine 5.6 Billion dollar market cap 52 week range $4.00-$110.00. todays price $94.00
MRNA Covid Phase 2 Vaccine 28 Billion market cap $64.00
INO Phase 1 Vaccine $2:00-$34.00 52 week range $26.00 today
VXRT preclinical Drug 52 week range .25-$14.00 1 Billion dollar market cap
CYDY .26-$10.00 2.75 Billion Market cap Phase 2 Drug CV-19
RVVTF .19 36 Million dollar market cap
Nearing Phase 3Covid-19 Drug with low side effects.
$RVVTF
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM